Structural Heart Disease
TIO 2023 – Atrioventricular Valve Replacement Beyond TEER?
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
HCM in Review: Highlights of 2022
- 0.25
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
HCM in Review: Assessing SCD Risk in HCM & Managing HCM With High Risk SCD
- 0.50
Published:
Learning objectives
- Recall risk factors associated with sudden cardiac death (SCD)
- Recall best practice approaches to prevent SCD according to guidelines and expert insight
- Stratify patients likely to benefit from invasive procedures versus pharmacological treatment
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
- 1.00
Published:
Learning objectives
- Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
- Summarise clinical evidence for TAVI in low surgical risk patients
- Recall different guideline recommendations for SAVR and TAVI approaches
- Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
HCM in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies
- 0.50
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
- Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities
HCM in Review: Highlights of ACC 2022
- 0.25
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
